Given that our studies only uncover CRKL is a critical transcriptional target of Hh‐GLI2 pathway in NSCLC cells, it will be interesting to test whether this transcriptional regulation also exists in other types of cancer. This evidence concerns the gene CRKL and non-small cell lung carcinoma.